Study of Vitamin D Level and Vitamin D Receptor Polymorphism in Hypothyroid Egyptian Patients

Table 1

Clinical and laboratory data of the two studied groups.

	Group
	Control group					Hypothyroid group					value
	Mean	SD	Median	Minimum	Maximum	Mean	SD	Median	Minimum	Maximum
BMI (kg/m^2)	24.53	3.91	24.20	18.60	33.80	29.29	5.61	29.00	21.80	46.50	<0.001
Vitamin D level (ng/ml)	48.54	12.57	50.00	16.00	65.00	24.20	10.78	21.00	10.00	47.00	<0.001
Anti-TG (IU/ml)	51.69	31.39	41.00	24.00	150.00	147.69	50.46	147.00	32.00	246.00	<0.001
Anti-TPO (IU/ml)	25.69	21.15	18.00	10.00	108.00	58.97	32.85	54.00	18.00	121.00	<0.001
TSH (mIU/ml)	2.75	0.72	2.70	1.40	4.12	25.02	31.61	10.50	4.98	112.00	<0.001
FT3	2.91	0.62	2.80	1.50	5.00	2.13	0.89	1.90	0.20	3.90	<0.001
FT4 (ng/dl)	1.27	0.32	1.30	0.70	1.80	0.92	0.35	0.90	0.20	1.50	<0.001
PTH (pg/ml)	27.94	12.85	24.00	13.00	62.00	75.99	21.62	77.00	45.00	120.00	<0.001
Ionized Ca	1.26	0.05	1.27	1.14	1.30	1.09	.18	1.10	0.70	1.31	<0.001
Total Ca (mg/dl)	9.60	0.54	9.60	8.50	10.50	8.75	.91	8.70	6.50	10.30	<0.001
P	4.53	0.53	4.80	3.50	5.30	4.07	.53	4.10	3.00	5.40	0.001
Mg	2.21	0.43	2.20	1.60	3.50	2.41	.55	2.20	1.70	3.80	0.108
ALP	81.23	23.78	82.00	43.00	140.00	95.03	28.38	90.00	55.00	159.00	0.031
F. insulin (mIU/L)	9.46	3.44	9.00	4.00	22.00	27.06	4.87	26.00	18.00	40.00	<0.001
F. glucose (mg/dl)	80.86	8.64	82.00	58.00	99.00	88.71	9.85	89.00	71.00	107.00	0.001
HOMA-IR	1.84	0.72	1.69	0.90	4.67	5.89	1.29	5.70	3.70	9.00	<0.001
T. vol (mL)	8.47	2.62	8.03	4.44	19.19	13.47	6.34	11.15	4.09	25.90	<0.001

Data presented by mean ± SD, median, and absolute range. value <0.05 is considered significant.